EU reaches deal with Moderna

EU reaches deal with Moderna for quicker vaccine supply.

THE European Commission announced today (December 16) that it has reached an agreement with Moderna for quicker vaccine supply of its mRNA jab to EU Member States that have a short-term need, in particular Germany, who are coping with sudden shortages amid booster shot campaign.

Moderna agreed to anticipate the delivery of 10 million doses to December for Germany. This is the equivalent of 20 million persons receiving a booster – as only half a dose is used for a booster.

In addition, Moderna will deliver 25 million extra doses to Germany in the first quarter of 2022 – the equivalent of an additional 50 million boosters.

A European Commission statement said: “In view of the rapid increase in infections due to the Omicron variant, and the need to scale up vaccination, including boosting, the Commission is working with vaccine manufacturers to further accelerate the delivery of vaccine doses to Member States that need additional doses in the short term.”

A further acceleration of deliveries by Moderna is being prepared for the first quarter of 2022, to the benefit of additional Member States.

The European Union said it has secured enough vaccines doses to vaccinate and administer booster shots to all Europeans, including children. “To date, more than 1 billion doses have been delivered to the EU Member States,” a statement read.

For more EU news, please click the link to read some of our other stories from around Europe.


Thank you for taking the time to read this article, do remember to come back and check The Euro Weekly News website for all your up-to-date local and international news stories and remember, you can also follow us on Facebook and Instagram.

FacebookTwitterRedditWhatsAppTelegramLinkedInEmailCopy Link
Go Back
Written by

Matthew Roscoe

Originally from the UK, Matthew is based on the Costa Blanca and is a web reporter for The Euro Weekly News covering international and Spanish national news. Got a news story you want to share? Then get in touch at [email protected]

Comments


    Leave a comment

    Your email address will not be published.